Esmero

Ahmedabad, India Founded: 2014 • Age: 12 yrs
Manufactures and supplies pharmaceutical products, nutraceuticals, and global market solutions.

About Esmero

Esmero is a Healthcare company based in Ahmedabad (India) founded in 2014. It manufactures and supplies pharmaceutical products, nutraceuticals, and global market solutions. It operates on a B2B model. Its Indian entity Esmero Research Private Limited reported revenue of β‚Ή21.30 Cr. Esmero offers products and services including Global Standard Products, Dynamic Solutions, Frontier Access, and Nutraceutical Supplements. Its focus areas include Health and Life Sciences, Pharmaceuticals, Manufacturing and Formulations. Its competitors include Syngene, Piramal Group and Panacea Biotec; 1 of its 3 listed competitors has raised funding.

Company details

Esmero Research Pvt. Ltd. is a pharmaceutical manufacturing company based in Ahmedabad, India, specializing in formulations for regulated, semi-regulated, and less-regulated markets. It offers products like Global Standard, Dynamic Solutions, and Nutraceutical Supplements, focusing on efficient supply chain integration and partnerships. The company supports clients worldwide with regulatory assistance, customized manufacturing, and quality assurance to bridge global pharma gaps.

Key Metrics
  • Annual Revenue
    ₹21.30 Cr

    FY 2024 · +24% YoY

  • Net Loss
    -₹55.7 Lakh

    FY 2024 · -3% margin

  • EBITDA
    ₹10.2 Lakh

    FY 2024 · 0% margin

Products & Services of Esmero

Esmero offers a comprehensive portfolio of products and services, including Global Standard Products, Dynamic Solutions, Frontier Access, and Nutraceutical Supplements.

Global Standard Products
Pharmaceutical Formulations

High-compliance formulations for regulated markets worldwide.

Dynamic Solutions
Pharmaceutical Formulations

Flexible solutions for semi-regulated market needs.

Frontier Access
Pharmaceutical Formulations

Innovative products for less-regulated emerging regions.

Nutraceutical Supplements
Health Supplements

Nutritional formulations for consumer health and wellness.

Board of directors of Esmero Research Private Limited (Esmero)

Esmero Research Private Limited is the primary company behind Esmero. The board of Esmero Research Private Limited currently have 2 directors; the longest-serving is Vinitkumar Subhashchandra Agrawal, appointed in 2014. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vinitkumar Subhashchandra Agrawal
DIN 02092679
Director05 Dec 201411 yrs 11 moEsmero Research Private Limited
Sneha Vinitkumar Agrawal
DIN 08051729
Director18 Jan 20206 yrs 9 moEsmero Research Private Limited

Financials of Esmero

Figures of Esmero Research Private Limited, the primary company behind Esmero, for FY 2024. Revenue was ₹21.30 Cr (+24% year on year). Net loss was -₹55.7 Lakh (-3% margin). EBITDA was ₹10.2 Lakh (0% margin). Revenue has grown at a compounded annual rate of +60% over three years and +81% over five years.

  • ₹21.30 CrRevenue · FY 2024 · +24% YoY
  • -₹55.7 LakhNet loss · -3% margin
  • ₹10.2 LakhEBITDA · 0% margin
  • ₹8.5 LakhPaid-up capital
  • +60%Revenue CAGR, 3 years
  • +81%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Esmero Research Private Limited are on its company page.

Premium access

Detailed financial statements for Esmero

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Esmero

Esmero has 3 listed competitors in our database, 1 of them funded. They include Syngene, Piramal Group and Panacea Biotec.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
syngeneintl.com1993Bengaluru, India$85.89M5,618
Provider of contract research and manufacturing services for both small molecules and biologics
piramal.com1984Mumbai, India204
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
panaceabiotec.com1984Ambala, India2,095
Developer of biosimilars, vaccines and natural products
Premium access

Detailed competitors of Esmero

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Esmero

The website of Esmero (esmero.co.in) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 1.1% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Esmero

Esmero was founded in 2014.

Esmero is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Esmero, Esmero Research Private Limited, reported revenue of β‚Ή21.30 Cr for FY 2024, up 24% year on year.

Esmero Research Pvt. Ltd. is a pharmaceutical manufacturing company based in Ahmedabad, India, specializing in formulations for regulated, semi-regulated, and less-regulated markets. It offers products like Global Standard, Dynamic Solutions, and Nutraceutical Supplements, focusing on efficient supply chain integration and partnerships. The company supports clients worldwide with regulatory assistance, customized manufacturing, and quality assurance to bridge global pharma gaps.

Esmero's top competitors include Syngene, Panacea Biotec and Piramal Group.

Esmero offers Global Standard Products, Dynamic Solutions, Frontier Access, and Nutraceutical Supplements.

Esmero operates through Esmero Research Private Limited.

The legal entities of Esmero currently have 2 directors, including Sneha Vinitkumar Agrawal, Vinitkumar Subhashchandra Agrawal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available